Clinical trial
Nicotine Treatment of Mild Cognitive Impairment (MCI)
NCT00091468 · National Institute on Aging (NIA), NIH · Unknown status
Key facts
| NCT number | NCT00091468 |
|---|---|
| Title | Nicotine Treatment of Mild Cognitive Impairment (MCI) |
| Official title | Double-Blind Treatment of Mild Cognitive Impairment (MCI) With Transdermal Nicotine or Transdermal Placebo |
| Lead sponsor | National Institute on Aging (NIA), NIH |
| Status | Unknown status |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Age-Related Memory Disorders |
| Intervention type | Drug |
| Interventions | Transdermal nicotine patch, Placebo transdermal patch |
| Enrollment | 75 |
| Start date | Sep 1, 2003 |
| Primary completion | Jul 1, 2008 |
| Completion | Jul 1, 2008 |
| First posted | Oct 14, 2004 |
| Last update posted | Jan 15, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: